Compare YUM & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YUM | HLN |
|---|---|---|
| Founded | 1997 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Restaurants | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5B | 41.7B |
| IPO Year | 1997 | N/A |
| Metric | YUM | HLN |
|---|---|---|
| Price | $154.31 | $9.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 1 |
| Target Price | ★ $163.00 | N/A |
| AVG Volume (30 Days) | 2.2M | ★ 10.3M |
| Earning Date | 02-05-2026 | 07-31-2025 |
| Dividend Yield | ★ 1.85% | 1.85% |
| EPS Growth | N/A | ★ 41.64 |
| EPS | ★ 5.13 | 0.23 |
| Revenue | $8,061,000,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $9.13 | $1.51 |
| Revenue Next Year | $9.53 | $4.67 |
| P/E Ratio | ★ $29.83 | $42.93 |
| Revenue Growth | ★ 11.60 | N/A |
| 52 Week Low | $122.13 | $8.71 |
| 52 Week High | $163.30 | $11.42 |
| Indicator | YUM | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 60.22 | 60.00 |
| Support Level | $150.67 | $9.68 |
| Resistance Level | $157.78 | $9.65 |
| Average True Range (ATR) | 3.18 | 0.15 |
| MACD | 0.66 | 0.02 |
| Stochastic Oscillator | 77.31 | 91.27 |
Yum Brands is a US-based restaurant operator featuring a portfolio of four brands: KFC (31,981 global units at year-end 2024), Pizza Hut (20,225 units), Taco Bell (8,757 units), and Habit Burger & Grill (nearly 400 units). With more than $65 billion in 2024 systemwide sales, the firm is the second-largest restaurant company in the world behind McDonald's ($131 billion). Yum is 98% franchised, with the largest franchisee, Yum China, spun out in 2016, after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity. Yum is the newest evolution of Tricon, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.